Study of CTX-471 as a Monotherapy or in Combination With Pembrolizumab in Patients Post PD-1/PD-L1 Inhibitors in Metastatic or Locally Advanced Malignancies
Compass Therapeutics
Compass Therapeutics
Eli Lilly and Company
Kivu Bioscience Inc.
Achieve Life Sciences
BicycleTx Limited
Astellas Pharma Inc
Eli Lilly and Company
7 Hills Pharma, LLC
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
Plexium, Inc.
Deciphera Pharmaceuticals, LLC
Revolution Medicines, Inc.
Pfizer
USWM, LLC (dba US WorldMeds)
AstraZeneca
Actuate Therapeutics Inc.
Conjupro Biotherapeutics, Inc.
Alterome Therapeutics, Inc.
Verastem, Inc.
IDEAYA Biosciences
Pfizer
Incyte Corporation
Aulos Bioscience, Inc.
Mirati Therapeutics Inc.
Eli Lilly and Company
Aptamer Sciences, Inc.
Eli Lilly and Company
AstraZeneca
Eli Lilly and Company
GlaxoSmithKline
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
Orano Med LLC
Conjupro Biotherapeutics, Inc.
Regeneron Pharmaceuticals
Novartis
Frontier Medicines Corporation
Boehringer Ingelheim
Eli Lilly and Company
PMV Pharmaceuticals, Inc
Ankyra Therapeutics, Inc
Daiichi Sankyo
N-Power Medicine
ViroMissile, Inc.
AstraZeneca
Novartis
Pfizer
Avenzo Therapeutics, Inc.
IntoCell, Inc
Pfizer
Tizona Therapeutics, Inc